Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Microbial Drug Resistance (Larchmont, N.Y.)|March 18, 2025
Comprehensive Genomic Analysis of Antimicrobial Resistance in <i>Aeromonas dhakensis</i>Ying-Wen Chen, Yu-Cheng Su, Wei-Yu Chen, et al.Molecular Pharmacology|August 5, 2006
Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitorPing-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, et al.Journal of Biomedical Science|April 27, 2026
Phosphatidylinositol transfer protein-1 integrates insulin/IGF-1 and TOR signaling to negatively regulate lifespan and healthspan in Caenorhabditis elegansYen-Hung Lin, Yun-Hsun Liao, Sin-Bo Liao, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 3, 2014
Aeromonas stool isolates from individuals with or without diarrhea in southern Taiwan: Predominance of Aeromonas veroniiPo-Lin Chen, Pei-Jane Tsai, Chang-Shi Chen, et al.Neuropharmacology|August 27, 2013
Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's diseaseRu-Huei Fu, Yu-Chi Wang, Chang-Shi Chen, et al.Nature Communications|January 5, 2021
Host CDK-1 and formin mediate microvillar effacement induced by enterohemorrhagic Escherichia coliCheng-Rung Huang, Cheng-Ju Kuo, Chih-Wen Huang, et al.Autophagy|November 23, 2016
HLH-30/TFEB-mediated autophagy functions in a cell-autonomous manner for epithelium intrinsic cellular defense against bacterial pore-forming toxin in C. elegansHuan-Da Chen, Cheng-Yuan Kao, Bang-Yu Liu, et al.Plos One|January 14, 2014
n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's diseaseRu-Huei Fu, Horng-Jyh Harn, Shih-Ping Liu, et al.Virulence|May 22, 2020
UvrY is required for the full virulence of <i>Aeromonas dhakensis</i>Yi-Wei Chen, Wen-Hsuan Yeh, Hung-Jen Tang, et al.Journal of the National Cancer Institute|October 7, 2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorderSameek Roychowdhury, Robert A Baiocchi, Srinivas Vourganti, et al.Pageof 6